Earnings results
Quarterly results as US companies announce them to the SEC (Form 8-K, Item 2.02), with figures from each company’s own filed statements. About half of companies file detailed figures the same day they announce; the rest show as pending until the quarterly statement arrives. No analyst estimates, no consensus: what was reported, compared with the same quarter a year earlier.
10,478 announcements in the last 12 months · page 14 of 105
| Announced | Company | Period | Revenue | Rev YoY | Net income | EPS | EPS YoY | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | Verrica Pharmaceuticals Inc. (VRCA) | Q2 FY2026 | $5.9M | -53.8% | $-13.2M | -0.62 | — | 8-K |
| 2026-08-06 | Viridian Therapeutics, Inc.\DE (VRDN) | Q2 FY2026 | $284,000 | 278.7% | $-127.1M | — | — | 8-K |
| 2026-08-06 | Versant Media Group, Inc. (VSNT) | Q2 FY2026 | $1.64B | -3.7% | $211.0M | 1.49 | -28.7% | 8-K |
| 2026-08-06 | Verastem, Inc. (VSTM) | Q2 FY2026 | $40.1M | 1775.4% | $-34.7M | -0.35 | — | 8-K |
| 2026-08-06 | Viatris Inc (VTRS) | Announced; detailed figures pending the quarterly statement | 8-K | |||||
| 2026-08-06 | Vaxart, Inc. (VXRT) | Q2 FY2026 | $27.2M | -31.6% | $-13.5M | — | — | 8-K |
| 2026-08-06 | Voyager Therapeutics, Inc. (VYGR) | Q2 FY2026 | $3.2M | -39.1% | $-24.5M | -0.40 | — | 8-K |
| 2026-08-06 | Warner Bros. Discovery, Inc. (WBD) | Q2 FY2026 | $8.72B | -11.2% | $149.0M | 0.06 | -90.5% | 8-K |
| 2026-08-06 | Walker & Dunlop, Inc. (WD) | Q2 FY2026 | $306.7M | -3.9% | $3.0M | 0.09 | -90.9% | 8-K |
| 2026-08-06 | Weave Communications, Inc. (WEAV) | Q2 FY2026 | $67.5M | 15.5% | $-4.3M | -0.05 | — | 8-K |
| 2026-08-06 | Westrock Coffee Co (WEST) | Q2 FY2026 | $305.7M | 8.8% | $-13.7M | -0.14 | — | 8-K |
| 2026-08-06 | WESTWOOD HOLDINGS GROUP INC (WHG) | Q2 FY2026 | $25.3M | 9.6% | $1.5M | 0.17 | 41.7% | 8-K |
| 2026-08-06 | Wheeler Real Estate Investment Trust, Inc. (WHLR) | Q2 FY2026 | $22.5M | -13.9% | $8.6M | — | — | 8-K |
| 2026-08-06 | Whitehawk Therapeutics, Inc. (WHWK) | Q2 FY2026 | $0 | — | $-16.6M | -0.20 | — | 8-K |
| 2026-08-06 | Willdan Group, Inc. (WLDN) | Q2 FY2026 | $231.0M | 33.2% | $24.3M | 1.58 | 53.4% | 8-K |
| 2026-08-06 | ADVANCED DRAINAGE SYSTEMS, INC. (WMS) | Q1 FY2027 | $1.00B | 20.6% | $168.5M | 2.19 | 19.0% | 8-K |
| 2026-08-06 | Warby Parker Inc. (WRBY) | Q2 FY2026 | $235.5M | 9.8% | $4.6M | 0.04 | — | 8-K |
| 2026-08-06 | WillScot Holdings Corp (WSC) | Q2 FY2026 | $612.2M | 3.9% | $47.0M | 0.26 | 0.0% | 8-K |
| 2026-08-06 | WHITE MOUNTAINS INSURANCE GROUP LTD (WTM) | Q2 FY2026 | $844.6M | 22.5% | $199.5M | 80.58 | 68.8% | 8-K |
| 2026-08-06 | Xeris Biopharma Holdings, Inc. (XERS) | Q2 FY2026 | $92.1M | 28.7% | $-31.1M | -0.18 | — | 8-K |
| 2026-08-06 | Xponential Fitness, Inc. (XPOF) | Q2 FY2026 | $66.0M | -13.4% | $-4.1M | -0.10 | — | 8-K |
| 2026-08-06 | Exzeo Group, Inc. (XZO) | Q2 FY2026 | $57.8M | 3.0% | $23.3M | 0.26 | 0.0% | 8-K |
| 2026-08-06 | YELP INC (YELP) | Q2 FY2026 | $375.5M | 1.4% | $31.7M | 0.57 | -14.9% | 8-K |
| 2026-08-06 | YORK WATER CO (YORW) | Q2 FY2026 | $23.4M | 22.7% | $7.6M | 0.49 | 40.0% | 8-K |
| 2026-08-06 | Zai Lab Ltd (ZLAB) | Q2 FY2026 | $105.8M | -3.1% | $-50.8M | -0.05 | — | 8-K |
| 2026-08-06 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Q2 FY2026 | — | — | $-42.3M | -0.59 | — | 8-K |
| 2026-08-06 | Zoetis Inc. (ZTS) | Q2 FY2026 | $2.47B | -0.2% | $691.0M | 1.65 | 1.2% | 8-K |
| 2026-08-06 | Zymeworks Inc. (ZYME) | Q2 FY2026 | $4.6M | -90.6% | $-45.0M | -0.62 | -2166.7% | 8-K |
| 2026-08-05 | AbCellera Biologics Inc. (ABCL) | Q2 FY2026 | $4.0M | -76.3% | $-55.4M | -0.18 | — | 8-K |
| 2026-08-05 | Arcosa, Inc. (ACA) | Q2 FY2026 | $658.7M | 1.7% | $328.5M | 6.67 | 446.7% | 8-K |
| 2026-08-05 | AMERICAN COASTAL INSURANCE Corp (ACIC) | Q2 FY2026 | $82.6M | -4.5% | $21.9M | 0.44 | -17.0% | 8-K |
| 2026-08-05 | Enact Holdings, Inc. (ACT) | Announced; detailed figures pending the quarterly statement | 8-K | |||||
| 2026-08-05 | ACACIA RESEARCH CORP (ACTG) | Q2 FY2026 | $114.6M | 123.6% | $47,000 | 0.00 | — | 8-K |
| 2026-08-05 | ADMA BIOLOGICS, INC. (ADMA) | Q2 FY2026 | $124.4M | 2.0% | $37.8M | 0.16 | 14.3% | 8-K |
| 2026-08-05 | Adient plc (ADNT) | Q3 FY2026 | $3.93B | 5.0% | $25.0M | 0.32 | -25.6% | 8-K |
| 2026-08-05 | Advantage Solutions Inc. (ADV) | Q2 FY2026 | $889.5M | 1.8% | $-62.7M | -4.85 | — | 8-K |
| 2026-08-05 | Aeva Technologies, Inc. (AEVA) | Q2 FY2026 | $6.1M | 11.3% | $-79.6M | -1.23 | — | 8-K |
| 2026-08-05 | AMERICAN FINANCIAL GROUP INC (AFG) | Q2 FY2026 | $2.03B | 5.5% | $248.0M | 2.99 | 44.4% | 8-K |
| 2026-08-05 | agilon health, inc. (AGL) | Q2 FY2026 | $1.49B | 7.2% | $18.0M | 1.04 | — | 8-K |
| 2026-08-05 | AIRGAIN INC (AIRG) | Q2 FY2026 | $13.7M | 0.6% | $-1.7M | -0.13 | — | 8-K |
| 2026-08-05 | A.K.A. BRANDS HOLDING CORP. (AKA) | Q2 FY2026 | $160.1M | -0.3% | $-161,000 | -0.01 | — | 8-K |
| 2026-08-05 | Akebia Therapeutics, Inc. (AKBA) | Q2 FY2026 | $49.1M | -21.4% | $-8.9M | -0.03 | — | 8-K |
| 2026-08-05 | ALBEMARLE CORP (ALB) | Q2 FY2026 | $1.74B | 31.1% | $480.0M | 3.52 | — | 8-K |
| 2026-08-05 | ALLSTATE CORP (ALL) | Q2 FY2026 | $18.60B | 11.8% | $3.27B | 12.51 | 61.2% | 8-K |
| 2026-08-05reported in filing | ALLIENT INC (ALNT) | Q2 FY2026 | $153.8M | 10.2% | $10.4M | 0.61 | 79.4% | 8-K |
| 2026-08-05 | Alto Ingredients, Inc. (ALTO) | Q2 FY2026 | $245.7M | 12.5% | $11.7M | 0.15 | — | 8-K |
| 2026-08-05 | Amplitude, Inc. (AMPL) | Q2 FY2026 | $100.9M | 21.2% | $-34.6M | -0.27 | — | 8-K |
| 2026-08-05 | AMERICAN SUPERCONDUCTOR CORP /DE/ (AMSC) | Q1 FY2027 | $94.1M | 30.0% | $9.5M | 0.20 | 17.6% | 8-K |
| 2026-08-05 | APA Corp (APA) | Q2 FY2026 | — | — | $747.0M | 2.11 | 26.3% | 8-K |
| 2026-08-05 | Apple Hospitality REIT, Inc. (APLE) | Q2 FY2026 | $402.6M | 4.7% | $67.1M | 0.28 | 3.7% | 8-K |
| 2026-08-05 | AppLovin Corp (APP) | Q2 FY2026 | $1.92B | 52.8% | $1.27B | 3.76 | 57.3% | 8-K |
| 2026-08-05 | Digital Turbine, Inc. (APPS) | Q1 FY2027 | $166.0M | 26.8% | $-11.3M | -0.09 | — | 8-K |
| 2026-08-05 | Archrock, Inc. (AROC) | Q2 FY2026 | $371.2M | -3.1% | $66.7M | 0.38 | 5.6% | 8-K |
| 2026-08-05 | Arcutis Biotherapeutics, Inc. (ARQT) | Q2 FY2026 | $129.9M | 59.3% | $15.0M | 0.11 | — | 8-K |
| 2026-08-05 | Array Technologies, Inc. (ARRY) | Q2 FY2026 | $342.1M | -5.6% | $24.3M | 0.05 | -73.7% | 8-K |
| 2026-08-05 | ASTEC INDUSTRIES INC (ASTE) | Q2 FY2026 | $408.1M | 23.6% | $10.5M | 0.45 | -37.5% | 8-K |
| 2026-08-05 | AMTECH SYSTEMS INC (ASYS) | Q3 FY2026 | $22.4M | 14.5% | $1.7M | 0.10 | 900.0% | 8-K |
| 2026-08-05 | A10 Networks, Inc. (ATEN) | Q2 FY2026 | $80.1M | 15.5% | $8.9M | 0.12 | -14.3% | 8-K |
| 2026-08-05 | Athene Holding Ltd. (ATH-PA) | Q2 FY2026 | $9.15B | 70.8% | $989.0M | — | — | 8-K |
| 2026-08-05 | ATMOS ENERGY CORP (ATO) | Q3 FY2026 | $879.1M | 4.8% | $242.7M | 1.43 | 23.3% | 8-K |
| 2026-08-05 | AVNET INC (AVT) | Q4 FY2026 | $8.30B | 47.7% | $126.6M | 1.52 | 2018.3% | 8-K |
| 2026-08-05 | AMERICAN STATES WATER CO (AWR) | Q2 FY2026 | $181.3M | 11.2% | $43.3M | 1.09 | 25.3% | 8-K |
| 2026-08-05 | AXON ENTERPRISE, INC. (AXON) | Q2 FY2026 | $904.4M | 35.3% | $29.4M | 0.36 | -18.2% | 8-K |
| 2026-08-05 | Atlanta Braves Holdings, Inc. (BATRA) | Q2 FY2026 | $305.1M | -2.3% | $-12.2M | -0.19 | -141.3% | 8-K |
| 2026-08-05 | Barings BDC, Inc. (BBDC) | Announced; detailed figures pending the quarterly statement | 8-K | |||||
| 2026-08-05 | BARRETT BUSINESS SERVICES INC (BBSI) | Q2 FY2026 | $319.3M | 3.8% | $12.9M | 0.52 | -25.7% | 8-K |
| 2026-08-05 | BRINKS CO (BCO) | Q2 FY2026 | $1.39B | 7.1% | $44.4M | 1.07 | 3.9% | 8-K |
| 2026-08-05 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Q2 FY2026 | $218.3M | 33.6% | $78.4M | 0.30 | 1400.0% | 8-K |
| 2026-08-05 | BIODESIX INC (BDSX) | Q2 FY2026 | $26.9M | 34.2% | $-7.3M | -0.71 | — | 8-K |
| 2026-08-05 | Black Diamond Therapeutics, Inc. (BDTX) | Q2 FY2026 | $0 | — | $-9.9M | -0.17 | — | 8-K |
| 2026-08-05 | BGSF, INC. (BGSF) | Q2 FY2026 | $22.3M | -5.1% | $-834,000 | — | — | 8-K |
| 2026-08-05 | Brighthouse Financial, Inc. (BHF) | Q2 FY2026 | $1.62B | 86.2% | $981.0M | 16.53 | 1520.6% | 8-K |
| 2026-08-05 | Braemar Hotels & Resorts Inc. (BHR) | Q2 FY2026 | $171.0M | -4.5% | $7.0M | — | — | 8-K |
| 2026-08-05 | BLACK HILLS CORP /SD/ (BKH) | Q2 FY2026 | $440.6M | 1.1% | $38.2M | 0.50 | 31.6% | 8-K |
| 2026-08-05 | Blue Bird Corp (BLBD) | Q3 FY2026 | $517.2M | 29.9% | $185.3M | 5.27 | 370.5% | 8-K |
| 2026-08-05 | BillionToOne, Inc. (BLLN) | Q2 FY2026 | $109.4M | 64.4% | $8.1M | 0.15 | — | 8-K |
| 2026-08-05 | Bloomin' Brands, Inc. (BLMN) | Q2 FY2026 | $1.02B | 1.3% | $31.3M | 0.36 | 20.0% | 8-K |
| 2026-08-05 | Bumble Inc. (BMBL) | Q2 FY2026 | $210.5M | -15.2% | $-110.1M | -0.84 | — | 8-K |
| 2026-08-05 | Dutch Bros Inc. (BROS) | Q2 FY2026 | $550.9M | 32.5% | $37.4M | 0.28 | 40.0% | 8-K |
| 2026-08-05 | biote Corp. (BTMD) | Q2 FY2026 | $44.2M | -9.5% | $-6.6M | -0.23 | -330.0% | 8-K |
| 2026-08-05 | Bioventus Inc. (BVS) | Q2 FY2026 | $153.2M | 3.8% | $33.4M | 0.47 | 327.3% | 8-K |
| 2026-08-05 | BORGWARNER INC (BWA) | Q2 FY2026 | $3.65B | 0.3% | $277.0M | 1.34 | 30.1% | 8-K |
| 2026-08-05 | BEYOND MEAT, INC. (BYND) | Q2 FY2026 | $68.8M | -8.2% | $16.4M | — | — | 8-K |
| 2026-08-05 | CACI INTERNATIONAL INC /DE/ (CACI) | Q4 FY2026 | $2.71B | 17.6% | $156.8M | 7.05 | -1.2% | 8-K |
| 2026-08-05 | Caris Life Sciences, Inc. (CAI) | Q2 FY2026 | $263.7M | 45.4% | $-637,000 | 0.00 | — | 8-K |
| 2026-08-05 | CrossAmerica Partners LP (CAPL) | Q2 FY2026 | $1.18B | 22.6% | $20.8M | 0.52 | -18.8% | 8-K |
| 2026-08-05 | CARLSMED, INC. (CARL) | Q2 FY2026 | $18.9M | 56.7% | $-10.5M | -0.39 | — | 8-K |
| 2026-08-05 | Clear Channel Outdoor Holdings, Inc. (CCO) | Q2 FY2026 | $438.0M | 8.7% | $-5.3M | -0.01 | -150.0% | 8-K |
| 2026-08-05 | Coeur Mining, Inc. (CDE) | Q2 FY2026 | $1.09B | 125.9% | $121.9M | 0.12 | 9.1% | 8-K |
| 2026-08-05 | Cardlytics, Inc. (CDLX) | Q2 FY2026 | $36.9M | -36.5% | $-14.9M | — | — | 8-K |
| 2026-08-05 | Cadre Holdings, Inc. (CDRE) | Q2 FY2026 | $207.1M | 31.8% | $11.4M | 0.26 | -13.3% | 8-K |
| 2026-08-05 | CDW Corp (CDW) | Q2 FY2026 | $6.57B | 10.0% | $274.4M | 2.15 | 4.9% | 8-K |
| 2026-08-05 | CENTRAL GARDEN & PET CO (CENT) | Q3 FY2026 | $882.4M | -8.2% | $89.9M | 1.45 | -4.6% | 8-K |
| 2026-08-05 | CF Industries Holdings, Inc. (CF) | Q2 FY2026 | $2.22B | 17.6% | $869.0M | 4.73 | 99.6% | 8-K |
| 2026-08-05 | CF Industries Holdings, Inc. (CF) | Q2 FY2026 | $2.22B | 17.6% | $869.0M | 4.73 | 99.6% | 8-K |
| 2026-08-05 | Carlyle Group Inc. (CG) | Q2 FY2026 | $1.12B | -28.6% | $137.1M | 0.37 | -57.5% | 8-K |
| 2026-08-05 | COGNEX CORP (CGNX) | Q2 FY2026 | $291.3M | 16.9% | $72.8M | 0.43 | 79.2% | 8-K |
| 2026-08-05 | CHOICE HOTELS INTERNATIONAL INC /DE (CHH) | Q2 FY2026 | $440.8M | 3.4% | $64.3M | 1.41 | -19.4% | 8-K |
| 2026-08-05 | Chord Energy Corp (CHRD) | Q2 FY2026 | $2.17B | 84.0% | $525.2M | 9.28 | — | 8-K |
| 2026-08-05 | Coherus Oncology, Inc. (CHRS) | Q2 FY2026 | $14.3M | 39.5% | $-20.6M | -0.13 | -105.1% | 8-K |
Source: SEC EDGAR. Figures are as reported in each company’s filings and may be unaudited or restated; a company that announces results in more than one filing (for example a delivery report and an earnings release) appears once per filing. Most rows come from an earnings release (Form 8-K, Item 2.02). Some companies file no separate release, so their periodic report is the event and the row is marked “reported in filing”. Foreign private issuers appear only where their Form 6-K tags the financial data itself, which is a minority of them: many report half-yearly, so there is no quarter to show and they are left out rather than listed without figures. Informational only. Not investment advice.